Citigroup Lowers Clorox (NYSE:CLX) Price Target to $130.00

Clorox (NYSE:CLX) had its price target cut by Citigroup from $135.00 to $130.00 in a research note issued to investors on Wednesday, Marketbeat.com reports. The firm currently has a “neutral” rating on the stock. Citigroup’s price target indicates a potential upside of 8.35% from the company’s current price.

Several other research analysts have also recently issued reports on the company. Barclays reduced their price objective on Clorox from $118.00 to $112.00 and set an “underweight” rating for the company in a research note on Tuesday, September 30th. The Goldman Sachs Group reduced their price objective on Clorox from $115.00 to $110.00 and set a “sell” rating for the company in a research note on Wednesday, October 1st. UBS Group reduced their price objective on Clorox from $134.00 to $128.00 and set a “neutral” rating for the company in a research note on Wednesday. Morgan Stanley reduced their price objective on Clorox from $150.00 to $137.00 and set an “equal weight” rating for the company in a research note on Friday, August 1st. Finally, Bank of America reduced their price objective on Clorox from $135.00 to $125.00 and set a “neutral” rating for the company in a research note on Wednesday. One research analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Reduce” and a consensus price target of $132.54.

Clorox Trading Up 0.3%

Clorox stock opened at $119.98 on Wednesday. The stock has a 50-day moving average of $122.27 and a two-hundred day moving average of $128.94. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. Clorox has a one year low of $116.53 and a one year high of $171.37. The stock has a market cap of $14.67 billion, a PE ratio of 18.40, a price-to-earnings-growth ratio of 0.98 and a beta of 0.52.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $1.94 billion. During the same period last year, the business posted $1.82 earnings per share. The company’s revenue for the quarter was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, research analysts anticipate that Clorox will post 7.15 EPS for the current fiscal year.

Insider Buying and Selling

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the firm’s stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the sale, the chief operating officer directly owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.57% of the company’s stock.

Institutional Trading of Clorox

Institutional investors have recently made changes to their positions in the company. Simplicity Wealth LLC boosted its stake in shares of Clorox by 157.3% in the second quarter. Simplicity Wealth LLC now owns 18,316 shares of the company’s stock worth $2,199,000 after acquiring an additional 11,198 shares during the last quarter. Raymond James Financial Inc. lifted its position in Clorox by 15.6% during the first quarter. Raymond James Financial Inc. now owns 269,926 shares of the company’s stock worth $39,747,000 after buying an additional 36,352 shares in the last quarter. OneDigital Investment Advisors LLC purchased a new position in Clorox during the first quarter worth approximately $247,000. Brown Miller Wealth Management LLC purchased a new position in Clorox during the first quarter worth approximately $399,000. Finally, Roman Butler Fullerton & Co. purchased a new position in Clorox during the first quarter worth approximately $400,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.